Access Failure
92.6% of women have never been screened for cervical cancer. HPV self-sampling kits exist in the system, but community reach is effectively zero.
Women's Health Access Initiative
Connecting women to healthcare innovation across Africa
AHA closes the critical gap between clinically proven health products and the 26 million Kenyan women who need them through last-mile distribution, pharmacy channel activation, and digital health financing.
26M
Kenyan women in the target access population
92.6%
Women who have never been screened for cervical cancer
355
Maternal mortality per 100,000 live births
$75B
Projected global femtech market by 2033
Kenya loses 12 women daily to cervical cancer, a disease that is almost entirely preventable. AHA is the market access partner that closes this gap.
Who We Are
Kenya's specialist women's health market access consultancy
ArchImpact Health Advisory (AHA) closes the gap between clinically proven health products and the women who need them, with one accountable team on the ground.
AHA is a women-led consultancy whose partners bring more than 15 years of combined experience in health market access, health systems strategy advisory, and digital health across East Africa.
We combine last-mile community distribution, pharmacy channel activation, digital health system integration, donor programme support, and regulatory navigation into a single delivery partner.
We are the translation layer between global health innovation and Kenyan women.
Community Health Volunteers
Pharmacy and e-pharmacy activation
Digital financing and micropayments
PPB and KEBS navigation
Donor programme delivery
KOL mapping and prescriber education
The Problem We Are Solving
Kenya's women's health gap is structural, not coincidental
Clinically proven products are registered and available somewhere in the system. The vast majority of Kenyan women still cannot access them. Five failures define the landscape.
Maternal Health Failure
Kenya's maternal mortality ratio stands at 355 per 100,000 live births. Proven maternal health technologies remain absent from pharmacy channels and last-mile access points.
Diagnostic Failure
PCOS and endometriosis take 7 to 10 years to diagnose. Kenya has no functional specialist referral pathway for reproductive endocrinology in either sector.
Innovation Gap
World-class femtech, contraceptive products, biodegradable menstrual products, and menopause formulations exist globally but often never enter Kenya.
Funding Execution Failure
Donor resources flow into Kenya's women's health ecosystem, but stockouts, absent resupply models, and fragmented local expertise limit impact.
AHA exists to close these gaps by combining regulatory navigation, commercial channel expertise, community health infrastructure, and donor programme management into a single, accountable partner.
Our Operating Model
The ArchImpact Women's Health Access Model
Three mutually reinforcing pillars move products from available somewhere to in every woman's hands.
Pillar 1
01
Last-Mile Distribution via Community Health Volunteers
Kenya's 100,000+ trained CHVs, overseen by county health departments, are the most powerful and under-leveraged distribution asset in the country. AHA trains CHVs on product use, equips them with product samples and referral forms, and tracks community uptake through digital data collection.
A clinically proven product can reach a woman in a rural village within 48 hours of her CHV visit.
Pillar 2
02
Pharmacy and E-Pharmacy Channel Optimisation
Kenya's formal pharmacy infrastructure is the primary touchpoint for women with purchasing power. AHA curates dedicated women's health sections, runs Pharmacist Champion incentive programmes, and optimises product pages for search, conversion, and subscription.
A woman can locate, purchase, or order any listed product within 15 minutes of deciding to seek it.
Pillar 3
03
Digital Health Financing and Micropayment Integration
Out-of-pocket cost remains the single largest barrier to women's health access. The Salama Mama bundle model combines curated product bundles with women's chama structures, mobile money micropayment plans, and health benefit package design.
No woman is turned away because she cannot pay the full amount upfront.
Strategic Focus Areas
Five niches chosen for urgency, policy alignment, and proven ability to deliver
Each focus area was selected for market urgency, alignment with Kenya's national health priorities, and AHA's ability to add measurable value from day one.
Cervical Cancer Access and Prevention
Kenya loses 12 women daily to cervical cancer, a disease that is almost entirely preventable. HPV self-sampling offers a community-level screening shift that does not require a clinical setting.
The Gap: 92.6% of women never screened; HPV kits exist but community reach is near zero.
AHA Entry Point: CHV-delivered HPV self-sampling, pharmacist referral pathways, HPV vaccination linkage at community contact
Maternal Nutrition and Health Technology
The Salama Mama model targets the critical 1,000-day window by integrating maternal nutrition supplements into pharmacy chains, building CHV distribution networks, and introducing affordable antenatal monitoring tools.
The Gap: Evidence-based maternal supplements remain in limited pilots; stockouts are endemic; monitoring tools are absent at community level.
AHA Entry Point: Pharmacy channel listing, Salama Mama bundles, CHV distribution with digital tracking
Contraception Access and Reproductive Wellness
With 14% unmet contraceptive need nationally, rising to 38% in marginalised counties, Kenya's family planning infrastructure has critical last-mile continuity failures.
The Gap: 14% unmet need nationally; 38% in marginalised counties; 35% discontinuation rate within 12 months.
AHA Entry Point: CHV continuity support, e-pharmacy subscription models, micropayment financing
Menopause and Women 40+ Health
Kenya's female population aged 40+ is the fastest-growing demographic cohort, yet virtually no clinical or retail pathway for menopause management exists.
The Gap: No clinical or retail menopause pathway; unregistered formulations; limited workplace wellness coverage.
AHA Entry Point: KOL prescriber education, PPB-compliant registration, pharmacy curation, corporate wellness advisory
Women's Health Financing
Out-of-pocket costs are the leading structural barrier across every focus area. AHA designs benefit packages, microinsurance products, employer wellness structures, and chama-based group health savings models.
The Gap: UHC transition creates architecture, but women's health-specific benefit packages are still missing.
AHA Entry Point: Curated benefit packages, microinsurance with mobile money, employer wellness, chama-based health savings
How We Work With Partners
Our curated service portfolio
Some partners come with a product, some with funding, and some with a market entry challenge. We design the engagement around the problem, not a standard template.
Market Access and Underperformance Audit
A structured diagnostic that identifies why a product is not moving across channels, pricing, messaging, regulatory gaps, or pharmacist knowledge deficits.
For: Pharma, femtech and diagnostics companiesRegulatory Navigation and Channel Entry
PPB/KEBS registration, LTR agreement facilitation, pharmacy chain listing, HCP activation, and post-listing performance monitoring.
For: International MedTech, femtech and nutraceutical brandsPharmacist Champion Programme
Structured training modules, clinical dispensing protocols, client counselling scripts, and e-pharmacy page optimisation.
For: Products in-market but underperformingCHV Access Integration
A donor-funded pilot model covering CHV selection, training, product provisioning, digital monitoring, and impact reporting.
For: Donors, county governments and NGOsMarket Entry Advisory
Market landscape analysis, KOL network mapping, competitor channel intelligence, regulatory roadmap, and pricing strategy.
For: Global health companies entering East AfricaCapacity Building and Training
CPD-accredited training for county health teams, midwives, pharmacists, and community health promoters.
For: NGOs, county governments and multilateral agenciesDonor Programme Support
Proposal development, sub-grantee management, M&E framework design, demand-generation execution, and donor reporting.
For: Development partners and implementing organisationsDigital Healthcare Platform Integration
Integration into telehealth platforms, e-pharmacy channels, telemedicine systems, and county health information systems.
For: E-pharmacies, digital health platforms and county systemsCorporate Wellness Advisory
Women's health benefit design and programme delivery for female-majority workforces.
For: Corporates, multinationals and employer groups
Our Track Record
Company experience proven across Kenya
AHA partners bring more than 15 years of combined experience across health market access, health systems strategy, telehealth, teleradiology, and e-pharmacy.
2020
Doctor Booking and Telehealth Platform
Onboarded 1,500 healthcare professionals for telehealth consultations and designed Breast Cancer Month awareness campaigns.
Platform live
2021
Women's Health Diagnostics - Teleradiology
Obstetric ultrasound reporting by subspecialised radiologists, with X-ray, CT, and MRI reading support for county hospitals.
70+ hospitals - Active
2024
Paediatric Eye Screening and Disease Management
Community-based eye screening and structured referral pathway in a marginalised county.
Complete
2024-25
County Telemedicine - Chronic Disease Management
Telemedicine deployment for remote monitoring and specialist consultation of chronic disease patients.
Countywide - Complete
2026
Women's Health Market Access - International Wellness Brand
PPB approval pathway and pharmacy channel entry strategy for an international women's wellness brand entering Kenya.
Current - On track
Ongoing
Total Health Reset - Mental Wellness Programme
Mental health support programme design and delivery integrated into the women's health continuum of care.
Active
Partnership and Investment
The window to lead women's health in Kenya is now.
Kenya's 2026-2030 Cervical Cancer Elimination Plan, the Social Health Authority rollout, and growing global femtech investment are converging. AHA is positioned to be the trusted local partner that makes your investment work.
Priority access to AHA proprietary market intelligence and channel mapping for Kenya
Co-design rights on Salama Mama, CHV Access Integration, and e-pharmacy subscription models
Named recognition in donor programme proposals and development partner submissions
Quarterly briefings on regulatory, policy, and competitive landscape developments
Preferred commercial terms on the full service portfolio for the founding partnership period
First right of refusal on category-exclusive partnerships within specific product verticals